Single Electron Transistor Platform for Microgravity Proteomics, Phase II

This Phase II program builds from the successful Phase I efforts to demonstrate that Quantum Logic Devices' nanoelectronic platform for biological detection could detect binding of Epo, TNF-alpha, IL-6, and IGF-1 in saline and serum without labels. The creation of an electronic "direct detection" platform for proteomics, enables rapid point of care monitoring of metabolic analytes in microgravity. This Phase II proposal will build working prototypes based on PDA-style electronic data capture with disposable assay cartridges for the analytes demonstrated in Phase I.

This is a mature technology (TRL 7+) — the realistic path in is usually NASA's Technology Transfer Program: licensing an existing NASA patent, or a Space Act Agreement to use NASA facilities/expertise directly. NASA also runs a startup licensing program with no upfront fee for companies formed to commercialize a specific NASA technology.

None of these are guaranteed paths for this specific project — TechPort itself doesn't have an "apply" button. Reaching out to the contact(s) above with a specific question is usually the fastest way to find out what's actually open.